Aspirin Market Report 2026

Aspirin Market Overview

• Aspirin market size has reached to $2.66 billion in 2025 • Expected to grow to $3.51 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Rising Cardiovascular Disease Burden Propels Aspirin Market • Market Trend: Driving Innovation in the Aspirin Market: Strategic Partnerships and Digital Health Initiatives • Asia-Pacific was the largest region in 2025.

What Is Covered Under Aspirin Market?

Aspirin is a non-steroidal anti-inflammatory drug used to treat fever and minor aches. The chemical name of aspirin is acetylsalicylic acid (ASA). It is used for treating conditions such as arthritis and to reduce the chance of problems such as heart attack and stroke. The major types of aspirin products are prescription and OTC. Prescription drugs are drugs that can only be bought through a certified physician’s prescription. By route of administration, it is segmented into oral, rectal, and parenteral. Several dosage forms of aspirin are tablets, capsules, injections, and suppositories. Aspirin is used in numerous applications, such as cardiovascular disease, pain, fever, inflammation, and others. These are used by various end-users, such as hospitals, clinics, and other end-users.

What Is The Aspirin Market Growth Forecast?

The aspirin market size is expected to see strong growth in the next few years. It will grow to $3.51 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to development of targeted aspirin therapies, adoption of advanced manufacturing technologies, increasing preventive healthcare initiatives, growing focus on cardiovascular disease prevention, expansion of global distribution channels. Major trends in the forecast period include personalized dosage formulations, expansion of otc aspirin availability, rising cardiovascular disease awareness, advanced drug delivery systems, increasing geriatric population usage.

Global Aspirin Market Segmentation

1) By Product: Prescription Aspirin, OTC (Over-the-Counter) Aspirin 2) By Route Of Administration: Oral, Rectal, Parenteral 3) By Dosage Form: Tablets, Capsules, Injections, Suppositories 4) By Application: Cardiovascular Disease, Pain, Fever, O Inflammation, Other Applications 5) By End User: Hospitals, Clinics, Other End Users Subsegments: 1) By Prescription Aspirin: Low-Dose Aspirin (81 Mg), High-Dose Aspirin (325 Mg) 2) By OTC (Over-the-Counter) Aspirin: Regular Strength Aspirin (325 Mg), Extra-Strength Aspirin (500 Mg), Buffered Aspirin, Aspirin Combinations

What Is The Driver Of The Aspirin Market?

The high burden of cardiovascular diseases worldwide is expected to propel the growth of the aspirin market going forward. Cardiovascular diseases refer to all the diseases that can affect the heart and blood vessels. Aspirin is often recommended as a preventive measure for cardiovascular diseases, particularly for individuals at risk of heart attacks or strokes. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, ischemic heart diseases resulted in 5,302 deaths, showing a slight increase from 5,290 deaths in 2022. Therefore, the high burden of cardiovascular diseases worldwide will drive the aspirin industry.

Key Players In The Global Aspirin Market

Major companies operating in the aspirin market are Bayer AG, Allegiant Health, Par Pharmaceutical, Cardinal Health Inc., Nanjing pharmaceutical factory Co. Ltd., JQC (Huayin) Pharmaceutical Co. Ltd., LNK International Inc., Bal Pharma Limited, Trumac Healthcare, Perrigo Company PLC, Alta Laboratories Ltd., Zhenjiang Gaopeng Pharmaceutical Co. Ltd., J.M. Loveridge Ltd., Mayne Pharma Group Limited, St. Joseph's Aspirin, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Hetero Labs Ltd., Jubilant Generics Ltd., Lupin Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd.

Global Aspirin Market Trends and Insights

Major companies operating in the aspirin market are adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in February 2023, Huma Therapeutics Limited ('Huma'), a UK-based digital health company, partnered with Bayer AG, a Germany-based life sciences company, to introduce the Bayer Aspirin Heart Risk Assessment online tool, which helps users identify their risk factors for developing cardiovascular disease over the next decade and allows them to share the results with their doctor. Huma has developed an algorithm that predicts long-term cardiovascular disease risk using data from the UK Biobank. Individuals can access the Heart Risk Assessment tool at Bayer Aspirin, where they will find a user-friendly questionnaire consisting of 15 questions. Based on their responses, the tool will assess whether they are at higher, average, or lower risk of developing cardiovascular disease by comparing their answers to those from the research population.

What Are Latest Mergers And Acquisitions In The Aspirin Market?

In May 2024, Sun Pharmaceutical Industries Ltd., an India-based specialty generic pharmaceutical company, acquired Taro Pharmaceutical Industries Ltd. for an undisclosed amount. The aim of the acquisition is to strengthen Sun Pharma's position in the pharmaceutical market, particularly in areas such as off-patent pharmaceuticals, prescriptions, and over-the-counter products. Taro Pharmaceutical Industries Ltd. is an Israel-based research-based pharmaceutical manufacturer that offers acetylsalicylic acid capsules.

Regional Insights

Asia-Pacific was the largest region in the aspirin market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Aspirin Market?

The aspirin market consists of sales of capsules, chewable, and coated tablets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Aspirin Market Report 2026?

The aspirin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the aspirin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.